Consensus for the Diagnosis and Treatment of Patients With Spinal Muscular Atrophy (SMA) in Latin America
Revista de Neurología · 2026
DOI: 10.31083/rn53782 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista de Neurología, 2026. Verfasst von Andrés E Nascimento Osorio und 39 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Neuromuscular, Hospital Sant Joan de Déu; Group of Applied Research in Neuromuscular Diseases, Institut de Recerca Sant Joan de Déu, 08950 …. Hauptthemen laut MEDLINE: Muscular Atrophy, Spinal. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roche and Novartis.
Abstract (Originalsprache)
Background
5q spinal muscular atrophy (5q SMA) is an autosomal recessive neuromuscular disorder caused by mutations in the survival motor neuron 1 gene (SMN1), leading to deficiency of SMN protein and a variable clinical spectrum influenced by survival motor neuron 2 gene (SMN2) copy number. The advent of disease-modifying therapies (DMTs) has transformed its clinical course, requiring timely diagnosis, multidisciplinary care, and longitudinal response assessment. In Latin America (LATAM), significant gaps and heterogeneity persist in access to genetic diagnosis, newborn screening, DMTs, and specialized follow-up. To develop a Latin American consensus providing recommendations for diagnosis, comprehensive management (respiratory, swallowing/nutrition, rehabilitation, and DMTs), and evaluation of response to DMTs in patients with SMA, incorporating real-world access considerations.
Methods
A regional expert panel conducted a formal consensus process (2025–2026) through iterative questionnaires and structured discussions. Agreement was defined as ≥70% concordance. Additionally, a regional survey assessed access to diagnostic and therapeutic resources.
Results
Forty professionals from 15 countries participated. While 90% reported access to genetic testing (MLPA), only 35% indicated availability within the public healthcare system; private access and pharmaceutical industry support were also reported as pathways to testing. No participating country reported nationwide implementation of newborn screening for SMA; 22.5% of respondents reported pilot programs or future implementation proposals. Access to at least one DMT was reported by 92.5% of respondents; however, delays between diagnosis and treatment initiation were frequent and remain an important challenge across the region. Consensus recommendations were established for diagnosis, functionally stratified multidisciplinary care, and response assessment based on motor and non-motor domains using validated tools and individualized follow-up.
Conclusions
This consensus provides a practical and adaptable framework to optimize SMA care in LATAM, supporting longitudinal, patient-centered clinical decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unidad de Neuromuscular, Hospital Sant Joan de Déu; Group of Applied Research in Neuromuscular Diseases, Institut de Recerca Sant Joan de Déu, 08950 Barcelona, España.
- Center for the Biomedical Research on Rare Diseases (CIBERER), ISCIII, 08036 Barcelona, España.
- Centro Hospitalario Pereira Rossell, Instituto de Neurología, 11600 Montevideo, Uruguay.
- Teletón Uruguay, 11600 Montevideo, Uruguay.
- Sección de Neurología Pediátrica, División de Pediatría, Escuela de Medicina, Pontificia Universidad Católica de Chile, 8331150 Santiago, Chile.
- Unidad de Neurología Pediátrica, Servicio de Pediatría, Hospital Dr. Sótero del Río, 8150215 Santiago, Chile.
Förderung
- Roche and Novartis
Zitieren
APA
Nascimento Osorio, A. E., Barros Acevedo, G., Beytía, M. L. Á., Bobadilla Quesada, E. J., Castellar-Leones, S. M., Castiglioni, C., Casartelli Galeano, M. J., Contreras Caicedo, G., Cordero Molina, M. F., Escobar Cedillo, R. E., Espinel, F., Earle, N., Franco Toñanez, C. A., Galvez Quiñonez, H. H., Gurgel-Giannetti, J., Gutiérrez Mata, A. P., Hervias Ruz, M. C., Linzoain, J. E., Lucero, M. A., …, & Armijo Gómez, J. A. (2026). Consensus for the Diagnosis and Treatment of Patients With Spinal Muscular Atrophy (SMA) in Latin America. Revista de Neurología. https://doi.org/10.31083/rn53782
Vancouver
Nascimento Osorio AE, Barros Acevedo G, Beytía MLÁ, Bobadilla Quesada EJ, Castellar-Leones SM, Castiglioni C, et al. Consensus for the Diagnosis and Treatment of Patients With Spinal Muscular Atrophy (SMA) in Latin America. Revista de Neurología. 2026. doi:10.31083/rn53782
BibTeX
@article{NascimentoOsorio2026,
author = {Nascimento Osorio, Andrés E and Barros Acevedo, Graciela and Beytía, María de Los Ángeles and Bobadilla Quesada, Edna J and Castellar-Leones, Sandra M and Castiglioni, Claudia and Casartelli Galeano, Marco J and Contreras Caicedo, Guilca and Cordero Molina, María Fernanda and Escobar Cedillo, Rosa E and Espinel, Francisco and Earle, Nicholas and Franco Toñanez, Carlos A and Galvez Quiñonez, Henry H and Gurgel-Giannetti, Juliana and Gutiérrez Mata, Alfonso P and Hervias Ruz, María C and Linzoain, Javier E and Lucero, Mariela A and Medici, Conrado and Mesa Restrepo, Sandra C and Meza Cano, María E and Monges, Soledad and Munive Baez, Leticia M and Núñez Antelo, Lourdes I and Odales Ibarra, Rogelio R and Artiga-Rodríguez, Verónica D and Pérez Almengor, Eva S and Martínez Esteban, Peggy C and Ramírez-Montaño, Diana and Moreno-Salgado, Rodrigo and Ruiz García, Matilde and Sáez Galaz, Verónica and Vargas Cañas, Edwin S and Bevilacqua, Jorge A and Zanoteli, Edmar and Zuniga García, Carol J and Gueçaimburu, María R and Gutiérrez-Saenz, Mario and Armijo Gómez, Jesús A},
title = {Consensus for the Diagnosis and Treatment of Patients With Spinal Muscular Atrophy (SMA) in Latin America},
journal = {Revista de Neurología},
year = {2026},
doi = {10.31083/rn53782}
}
EUVIMED